Device Repurposing in Research
How adapting existing tools can drive innovation
In this episode of Bio Break, Nick Allan and Nigel Syrotuck discuss device repurposing in research, sharing a story that blends microbiology, animal science, and engineering ingenuity. The episode begins with Nick examining an unusual medical device originally used for equine reproductive sampling. As Nigel jokes about its “unique” application, Nick explains how his team repurposed the tool to study bovine respiratory diseases during the COVID era.
The conversation highlights how adaptability is key in research. During supply shortages, Nick’s team used what they had—an equine sampling instrument—to collect deep nasal swabs from cattle for studying Mycoplasma bovis. This creative approach reflects the practical side of device repurposing in research: using proven, sterile, and available tools to advance science quickly and safely.
From animal care to microbiology
Nigel and Nick explore how one device can serve multiple disciplines when handled thoughtfully. Engineers often design instruments for a single, specific purpose. However, researchers in both human and veterinary medicine sometimes find safe, responsible ways to apply existing devices in new contexts. This not only saves time and cost but also helps teams continue important studies despite logistical barriers.
Engineering meets resourcefulness
As Nigel points out, clinicians and engineers must sometimes foresee off-label uses or modifications. Understanding these adaptations helps teams ensure safety while maintaining design integrity. The story reminds us that innovation doesn’t always start from scratch—sometimes it comes from seeing familiar tools in a new way.
By the end, both hosts emphasize that flexibility and informed adaptation can lead to new discoveries, whether in animal health or medical device design.
Enjoying Bio Break? Sign up to get new episodes sent to your inbox.
Related Resources
Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.
Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.
Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.
In this Bio Break episode, Nick and Nigel explore why some GLP-1 drugs are taken daily while others last a full week, and what drives that difference at a molecular level.